๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Adenovirus Infections

Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma NCT07538128EARLY Phase 11 site๐Ÿ“ Shanghai Huashan Hospital ยท Tests: YSCH-01, Atezolizumab (1200 mg every three weeks) Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals NCT02455479Phase 11 site๐Ÿ“ New York Weill Medical College of Cornell University ยท Tests: dAd5GNE Vaccine, Placebo YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With Unresponsive or Failure-Treated Cases NCT07697937Phase 21 site๐Ÿ“ Tianjin Tianjin First Central Hospital ยท Tests: YH-02 Third Party Viral Specific T-cells (VSTs) NCT02532452Phase 24 sites๐Ÿ“ Akron๐Ÿ“ Cincinnati๐Ÿ“ Cincinnati Children's Hospital Medical Center, Cincinnati ยท Tests: Viral Specific VST Infusion Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC NCT07565740Phase 11 site๐Ÿ“ Chengdu West China Hospital ยท Tests: WSK-IM05 (4ร—10^10 vp), WSK-IM05 (8ร—10^10 vp), WSK-IM05 (1.6x10^11 vp), Tislelizumab Viral Infections in Healthy and Immunocompromised Hosts NCT01306084n/a1 site๐Ÿ“ Bethesda National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease NCT03425526Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors NCT07625423Phase 11 site๐Ÿ“ Chengdu West China Hospital ยท Tests: EDS01 1.0ร—10^11 VP + Toripalimab, EDS01 5.0ร—10^11 VP + Toripalimab, EDS01 1.0ร—10^12 VP + Toripalimab A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture Systemยฎ NCT02007356Phase 21 site๐Ÿ“ Basel University Hospital, Basel, Switzerland ยท Tests: IFN-ฮณ positive selected T-cells Adenovirus (RGDCRAdCOX2F) NCT06693986Phase 11 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Replicative Adenovirus Vector (RGDCRAdCOX2F) Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections NCT04722029Phase 1, Phase 21 site๐Ÿ“ Columbus Nationwide Children's Hospital ยท Tests: Adenovirus Specific T lymphocytes A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT NCT07387367Phase 381 sites๐Ÿ“ Phoenix๐Ÿ“ Duarte๐Ÿ“ Palo Alto SymBio Pharmaceuticals ยท Tests: cidofovir, Brincidofovir R-MVST Cells for Treatment of Viral Infections NCT05183490Phase 11 site๐Ÿ“ New York Columbia University ยท Tests: Rapidly generated virus specific T (R-MVST) cells Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC) NCT07359235Phase 11 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: KD01(the recombinant oncolytic adenovirus) The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies NCT06552598Phase 11 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: KD01(the recombinant oncolytic adenovirus) A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV. NCT06617091Phase 13 sites๐Ÿ“ Mtubatuba๐Ÿ“ Cape Town๐Ÿ“ Harare International AIDS Vaccine Initiative ยท Tests: GRAdHIVNE1 Vaccine, Placebo Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation NCT03378102EARLY Phase 11 site๐Ÿ“ Cleveland Mari Dallas ยท Tests: IFN-gamma-secreting HAdV antigen specific T cells Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation NCT05664126Phase 21 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: VST infusion, CliniMACS Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910n/a1 site๐Ÿ“ Phnom Penh Institut Pasteur du Cambodge TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. NCT04013802Phase 12 sites๐Ÿ“ Houston๐Ÿ“ Houston Baylor College of Medicine ยท Tests: HLA-matched VSTs H101 Plus TACE for r/m HNSCC NCT07398664Phase 21 site๐Ÿ“ Chengdu West China Hospital ยท Tests: H101, TACE R-MVST Cells for Treatment of Viral Infections in Children and Young Adults NCT06926894Phase 11 site๐Ÿ“ New York Monica Bhatia ยท Tests: Rapidly generated virus specific T (R-MVST) cells The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise NCT01011712n/a1 site๐Ÿ“ Bethesda National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma NCT03896568Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Oncolytic Adenovirus Ad5-DNX-2401, Therapeutic Conventional Surgery YSCH-01 Via Nebulization in Pulmonary Metastasis of Advanced Solid Tumors and Non-small Cell Lung Cancer (NSCLC) NCT07793500EARLY Phase 11 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: YSCH-01, YSCH-01 Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity NCT06909110Phase 1, Phase 23 sites๐Ÿ“ Palo Alto๐Ÿ“ Palo Alto๐Ÿ“ Palo Alto Jessie L. Alexander ยท Tests: Adenovirus Specific T- Lymphocytes, Cytomegalovirus Specific T-Lymphocytes, Epstein-Barr Virus Specific T-Lymphocytes Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors NCT03740256Phase 11 site๐Ÿ“ Houston Baylor College of Medicine ยท Tests: CAdVEC Donor-Derived Viral Specific T-cells (VSTs) NCT02048332Phase 1, Phase 23 sites๐Ÿ“ Akron๐Ÿ“ Cincinnati๐Ÿ“ Cincinnati Children's Hospital Medical Center, Cincinnati ยท Tests: Viral specific VST Infusion Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections NCT04832607Phase 333 sites๐Ÿ“ Brussels๐Ÿ“ Brussels๐Ÿ“ Ghent Tobias Feuchtinger ยท Tests: Multivirus (CMV, EBV, AdV)-specific T cells Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone NCT07225972Phase 32 sites๐Ÿ“ Valhalla๐Ÿ“ Milwaukee New York Medical College ยท Tests: Standard of Care Antiviral medications, Viral CTLs
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy